SpaceX IPO launches today. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWatkin Jones Regulatory News (WJG)

Share Price Information for Watkin Jones (WJG)

Share Price is delayed by 15 minutes
Get Live Data
19.50    0.00 (0.00%)
Bid:
19.70
Ask:
19.88
Spread: 0.18 (0.914%)
Market Cap: £50.09m
WJG Live PriceLast checked at - London Stock Exchange

Intraday Watkin Jones Share Chart

Pre-Close Trading Statement

17 Nov 2016 07:00

RNS Number : 3933P
Watkin Jones plc
17 November 2016
 

For immediate release

17 November 2016

 

Watkin Jones plc

('Watkin Jones' or the 'Group')

 

Pre-Close Trading Statement

 

Watkin Jones plc (AIM:WJG), a leading UK developer and constructor of multi occupancy property assets, with a focus on the student accommodation sector, is pleased to provide a trading update for the year ended 30 September 2016 (the 'period').

 

The Board expects to report a successful financial year with trading in line with its expectations.

 

As announced on 27 September 2016, Watkin Jones successfully completed, ahead of the 2016/17 academic year, ten developments across the UK with a total of 3,819 student beds. Watkin Jones has a record of on-time delivery of schemes and all developments expected to be completed ahead of the 2017/2018 academic year, remain on track. The Group continues to add sites to its strong development pipeline and, at 30 September 2016, it had a total of 21 developments with 6,814 beds targeted for delivery during 2017 and 2018.

 

The Group's pipeline beyond 2018 is also looking robust with over 2,000 beds across a number of sites already secured. This includes the proposed redevelopment of the Duncan House site in Stratford, London, to provide 511 beds of student accommodation, 44 residential apartments and approximately 28,000 square feet of academic and office space. The scheme has a gross development value in excess of £100 million and is due for delivery in 2019.

 

Fresh Student Living, the Group's asset management subsidiary, continues to progress well, and now has 12,337 beds under management for the 2016/17 academic year (8,310 under management during the 2015/16 academic year).

 

The pipeline going forward provides the Group with strong visibility of earnings and cash flows and underpins our strategy in the near term. As a result, and with interest from investors in Purpose Built Student Accommodation remaining consistently strong, the Board remains confident in the outlook for the Group.

 

Mark Watkin Jones, Chief Executive Officer of Watkin Jones plc, said: "It has been a busy year for the Group and excellent progress has been made. Not only have we delivered 3,819 beds across ten sites in the UK, but we have also successfully made the transition to being a public company. Our performance in the year reinforces the attractiveness of our end-to-end business model to investors, whilst our development pipeline continues to provide excellent visibility of earnings and cashflow."

 

The Group will be announcing its Final Results on Wednesday, 18 January 2017. An analyst briefing will be held at 09.30hrs at the offices of Buchanan, 107 Cheapside, London EC2V 6DN.

 

- Ends -

 

For further information:

Watkin Jones plc

 

Mark Watkin Jones, Chief Executive Officer

Tel: +44 (0) 1248 362 516

Phil Byrom, Chief Financial Officer

www.watkinjonesplc.com

 

 

Zeus Capital Limited (Nominated Adviser & Joint Broker)

 

Corporate Finance

 

Dan Bate / Nick Cowles / Jamie Peel

Tel: +44 (0) 161 831 1512

Corporate Broking

Tel: +44 (0) 20 3829 5000

Dominic King / Benjamin Robertson

www.zeuscapital.co.uk

 

 

Peel Hunt LLP (Joint Broker)

Tel: +44 (0) 20 7418 8900

Mike Bell / Matthew Brooke-Hitching

www.peelhunt.com

 

 

 

Media enquiries:

Buchanan

 

Henry Harrison-Topham / Richard Oldworth / Jamie Hooper

Tel: +44 (0) 20 7466 5000

watkinjones@buchanan.uk.com

www.buchanan.uk.com

 

 

Notes to Editors

 

Watkin Jones is a leading UK developer and constructor of multi occupancy property assets, with a focus on the student accommodation sector. The Group has strong relationships with institutional investors, and a good reputation for successful, on-time-delivery of high quality developments. Since 1999, Watkin Jones has delivered over 31,800 student beds across 98 sites, making it a key player and leader in the UK purpose built student accommodation market. In addition, Watkin Jones has been responsible for over 50 residential developments, ranging from starter homes to executive housing and apartments.

 

The Group's competitive advantage lies in its experienced management team and business model, which enables it to offer an end to end solution for investors, delivered entirely in-house with minimal reliance on third parties, across the entire life cycle of an asset. Key components of the business model are:

 

· Site identification - extensive experience of site identification and acquisition facilitates high quality sites being acquired;

· Planning consents - in depth knowledge and experience of the planning consent process specific to this type of asset facilitates high success rates on planning applications;

· In-house construction and delivery - in-house construction expertise, management and delivery limits reliance on third parties and, together with favourable contractual relationships with key suppliers, enhances control of cost;

· Funding structure - forward sale model reduces risk for Watkin Jones and provides security and visibility of the asset pipeline for investors. The Group has strong relationships with blue chip investors, including a number that are repeat investors in Watkin Jones developments; and

· Asset management - dedicated property management division provides a continued service solution to investors post development completion and completes the 'end to end' business model.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTFFIFWMFMSEDF
Date   Source Headline
1st Jun 20267:00 amRNSChange of Registered Office
28th May 20263:00 pmRNSInvestor Presentation via Investor Meet Company
27th May 20267:00 amRNSHalf Year Results
19th May 20267:00 amRNSNotice of H1-2026 Results
1st May 20267:00 amRNSTotal Voting Rights
29th Apr 20267:00 amRNSHY 2026 Trading Update
13th Apr 20261:50 pmRNSHolding(s) in Company
1st Apr 20267:00 amRNSTotal Voting Rights
25th Mar 20264:20 pmRNSHolding(s) in Company
25th Mar 20264:14 pmRNSHolding(s) in Company
11th Mar 20262:39 pmRNSHolding(s) in Company
27th Feb 20267:00 amRNSDirector/PDMR Shareholding
4th Feb 20262:00 pmRNSResult of AGM
3rd Feb 202611:46 amRNSBlocklisting Application
28th Jan 20261:26 pmRNSHolding(s) in Company
20th Jan 20267:00 amRNSDirector/PDMR Shareholding
6th Jan 20267:00 amRNSAnnual Report and Notice of AGM
22nd Dec 20257:00 amRNSDevelopment Partnership for 294-unit hotel
22nd Dec 20257:00 amRNSDevelopment Partnership for 294-unit hotel
19th Dec 202512:02 pmRNS-RProgressive publishes new research
19th Dec 202512:02 pmRNS-RProgressive publishes new research
17th Dec 20258:17 amRNSPresentation via Investor Meet Company
16th Dec 20257:00 amRNSFull Year Results
15th Dec 20251:10 pmRNSWJ & Maslow Capital announce £102m PBSA scheme
21st Oct 20257:00 amRNSFY25 Trading Update
1st Oct 202510:44 amRNSHolding(s) in Company
30th Sep 20257:00 amRNSWatkin Jones announces £182m PBSA Joint Venture
10th Sep 20257:00 amRNSHolding(s) in Company
5th Sep 20257:00 amRNSAppointment of Joint Corporate Broker
4th Sep 202512:54 pmRNSHolding(s) in Company
12th Aug 20257:00 amRNSDevelopment Partnership for 200-unit PBSA scheme
1st Jul 20257:00 amRNSIssue of Sharesave options and PDMR shareholdings
29th May 20253:36 pmRNSPresentation via Investor Meet Company
29th May 20257:00 amRNSHalf Year Results
28th May 202511:56 amRNSHolding(s) in Company
22nd May 20257:00 amRNSNotice of H1-2025 Results
29th Apr 20257:00 amRNSHY25 Trading Update
4th Apr 20257:00 amRNSDirector/PDMR Shareholding
25th Mar 20257:00 amRNSHolding(s) in Company
4th Mar 20254:12 pmRNSNotification of Major Holdings
4th Mar 20252:26 pmRNSResult of AGM
12th Feb 20252:11 pmRNSNotification of Major Holdings
7th Feb 20257:50 amRNSAnnual Report and Notice of AGM
5th Feb 20257:00 amRNSDirector/PDMR Shareholding
31st Jan 20259:53 amRNSDevelopment Partnership for 260-unit Aparthotel
27th Jan 20254:59 pmRNS-RPresentation via Investor Meet Company
27th Jan 20254:55 pmRNSPresentation via Investor Meet Company
27th Jan 20251:23 pmRNSDirector/PDMR Shareholding
23rd Jan 20257:00 amRNSFull Year Results 2024
17th Jan 20257:00 amRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.